DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Härtter S, Koenen-Bergmann M, Sharma A , et al.
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.
Br J Clin Pharmacol 2012;
74 (3) 490-500
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.